Roche Holding Ag Stock News

LOS ANGELES, United States: The report offers an all-inclusive and accurate research study on the global Renal Drugs market while chiefly focusing on current and historical market scenarios. Stakeholders, market players, investors, and other market participants can significantly benefit from the

The market report delivers an all-inclusive analysis of the market structure along with a forecast of the various segments and sub-segments of the Smart Drug Delivery Solutions industry. This wide-ranging market research report acts as a backbone for the success

Novartis said it will use the proceeds from the recent sale of its stake in Roche Holding to buy back up to $15 billion of its shares by the end of 2023

This Communicable Diseases Drugs market report is the product of thorough market study and comments on important factors that influence financial decision. Here, helpful insights on customer demands are provided in order to launch the best product or service on

The Cytomegalovirus (CMV) Diagnostic research report combines vital data incorporating the competitive landscape, global, regional, and country-specific market size, market growth analysis, market share, recent developments, and market growth in segmentation. Furthermore, the Cytomegalovirus (CMV) Diagnostic research report offers information

Key Prominent Players Covered in the Enzymes Market are BASF, Codexis Inc., Amano Enzyme Inc., DSM, Dupont De Nemours & Co., ABF PLC, AB Enzymes, Dyadic International Inc., Advanced Enzyme Technology Ltd., Affymetrix Inc., Bbi Enzymes Ltd., Basf, Codexis Inc., Nagase & Co. Ltd., Life Technologies, Roche Holding Ag., Sanofi S.A. Key Prominent Players Covered in the Enzymes Market are BASF, Codexis Inc., Amano Enzyme Inc., DSM, Dupont De Nemours & Co., ABF PLC, AB Enzymes, Dyadic International Inc., Advanced Enzyme Technology Ltd., Affymetrix Inc., Bbi Enzymes Ltd., Basf, Codexis Inc., Nagase & Co. Ltd., Life Technologies, Roche Holding Ag., Sanofi S.A.

SOUTH SAN FRANCISCO (dpa-AFX) - Roche (RHHBY) said that it has launched the first infectious disease tests on the cobas 5800 System, a new molecular laboratory instrument, in countries accepting t

(RTTNews) - After a positive start and a subsequent long spell along the unchanged line, the Switzerland stock market started sliding around mid afternoon on Tuesday and eventually ended the session on a very weak note. The benchmark SMI ended down 139.70 points or 1.11% at 12,411.58, the day''s low. Richemont and Roche Holding both ended lower

Roche Holdings AG (OTC: RHHBY) announced results from the Phase 3 POLARIX study of Polivy (polatuzumab vedotin) with MabThera/Rituxan (rituximab) and the chemotherapy regimen R-CHOP. Data were presen

(RTTNews) - Genentech, a member of the Roche Group (RHHBY), said results from the Phase III POLARIX study showed that treatment with Polivy (polatuzumab vedotin) in combination with Rituxan (rituximab) plus cyclophosphamide, doxorubicin and prednisone (R-CHP) significantly reduced the risk of disease progression, relapse or death by 27%…

Polivy plus R-CHP is the first treatment regimen to significantly improve outcomes in previously untreated diffuse large B-cell lymphoma in more than 20 years, potentially transforming treatment fo…

SOUTH SAN FRANCISCO (dpa-AFX) - Roche Diagnostics, a subsidiary of Roche Holding AG (RHHBY) said it has obtained an approval to sell its newly introduced SARS-CoV-2 Antigen Self Test Nasal in Cana…

Related Stocks: 6988 , SHL , ROG , NOVN , 8035 , SAN , CRGI , BEI , NOVOB , UCB , 4528 , 7203 , 4507 , DB1 ,

Complete study of the global Benzodiazepines market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of the present